Theravance Biopharma, Inc. (TBPH)
19.50
-0.98
(-4.79%)
USD |
NASDAQ |
Feb 09, 16:00
19.51
+0.01
(+0.05%)
After-Hours: 20:00
Theravance Biopharma Accounts Payable (Quarterly) : 2.213M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 34.45M |
| Nektar Therapeutics | 15.56M |
| Innoviva, Inc. | 6.243M |
| Oramed Pharmaceuticals, Inc. | 0.56M |
| Skye Bioscience, Inc. | 2.825M |